Recerca > Epidemiologia, Malalties infeccioses i Salut pública

Farmacologia i Microbiologia Molecular

Nombre de publicacions
243
Cercador de publicacions

  • Borrás Pérez, V.; López-Siguero, J.P.; Martínez, G.; Corripio, R.; Fernández, J.M.; Labarta, J.I.; Ferrer, M.; Cabrinety, N.; Prieto, P.; Ramón-Krauel, M.; Bosch, J.; Espino, R.; Palla Garcia, M.; Rebollo, F.J.

    A Follow-up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope(A (R))) During a Phase III Clinical Trial

    Advances in Therapy 32 148-156. .

    [doi:10.1007/s12325-015-0181-9]

  • Huerva V; Ascaso FJ; Grzybowski A

    Ocular Inflammation

    Mediators of Inflammation 2015 398076-398076. .

    [doi:10.1155/2015/398076]

  • Huerva V

    Lichen planus on the ocular surface

    Cutaneous And Ocular Toxicology 34 232-233. .

    [doi:10.3109/15569527.2014.944651]

  • Huerva V; Sánchez MC; Ascaso FJ; Soldevila J

    Late postoperative capsular block syndrome: a case series studied before and after Nd:YAG laser posterior capsulotomy

    EUROPEAN JOURNAL OF OPHTHALMOLOGY 25 27-32. .

    [doi:10.5301/ejo.5000507]

  • Ribas J; Mattiolo P; Boix J

    Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment

    CURRENT DRUG TARGETS 16 31-37. .

    [doi:10.2174/1389450115666141114153536]

  • de la Torre-Ruiz MA; Pujol N; Sundaram V

    Coping With Oxidative Stress. The Yeast Model

    CURRENT DRUG TARGETS 16 2-12. .

    [doi:10.2174/1389450115666141020160105]

  • De La Torre Ruiz MA

    Unraveling oxidative stress. From yeast to human therapy.

    CURRENT DRUG TARGETS 16 1-1. .

  • Milara J; Outeda-Macias M; Aumente-Rubio MD; Más-Serrano P; Aldaz A; Calvo MV; García-Simón MS; Martin-Barbero M; Padullés-Zamora N; Schoenenberger JA; Saavedra-Aldrich M; Tévar-Alfonso E; Saval A; Pastor-Clerigues A; García M; Margusino-Framiñan L; Montero-Alvarez JL; Merino E; Herrero JI; Beunza M; Conesa-Zamora P; Gimenez-Manzorro A; Comas-Sugrañes D; Cano-Marron M; Jiménez-Mutiloa E; Díaz-Ruíz P; Cortijo J

    PEG-Interferon-a ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.

    FARMACIA HOSPITALARIA 39 29-43. .

    [doi:10.7399/fh.2015.39.1.8547]

  • De La Torre Ruiz, MA

    Unraveling Oxidative Stress. From Yeast to Human Therapy

    CURRENT DRUG TARGETS 16 3-3. .

  • Muniesa, M.; March, A.; Sánchez-De-La-Torre, M.; Huerva, V.; Jurjo, C.; Barbé, F.

    Erratum: Corneal biomechanical properties in floppy eyelid syndrome (Cornea (2015) 34 (521-524))

    Cornea 34 19-19. .

    [doi:10.1097/ICO.0000000000000488]

  • Rius, J.; Zapata, A.; Ahmad, F.; Schoeneneberger, J.A.

    Use of a pharmacotherapeutic reconciliation process based on "STOPP" criteria applied to patients older than 70 years old admitted in the hospital

    Circular Farmaceutica 73 13-18. .

  • Martinez-Alonso, M; Dusso, A; Ariza, G; Nabal, M

    The effect on quality of life of vitamin D administration for advanced cancer treatment (VIDAFACT study): protocol of a randomised controlled trial

    Bmj Open 4 -. .

    [doi:10.1136/bmjopen-2014-006128]